/r/LungCancerSupport

Year:

Only show posts with narrations

Patient-reported outcomes in CodeBreak 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation

1 upvotes • WalkingHorse

Mark as read: Add to a list

Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer

1 upvotes • WalkingHorse

Mark as read: Add to a list

BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer

1 upvotes • WalkingHorse

Mark as read: Add to a list

Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer | Cancer Epidemiology, Biomarkers & Prevention

1 upvotes • WalkingHorse

Mark as read: Add to a list

Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitor Treatment for Metastatic Non-small Cell Lung Cancer Throughout the Entire Gestation Period

1 upvotes • WalkingHorse

Mark as read: Add to a list

Aspergillus fumigatus Is Dual-Tracer 18FDG/68Ga-FAPI PET/CT Capable of Distinguishing Fungal Infection and Unspecific Inflammation From Recurrent Lung Cancer?

1 upvotes • WalkingHorse

Mark as read: Add to a list

FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A/STAT3 transcription mechanism | Journal of Experimental & Clinical Cancer Research

1 upvotes • WalkingHorse

Mark as read: Add to a list

A case of organizing pneumonia in rearranged during transfection fusion-positive lung adenocarcinoma treated with selpercatinib

1 upvotes • WalkingHorse

Mark as read: Add to a list

Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth

1 upvotes • WalkingHorse

Mark as read: Add to a list

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer

1 upvotes • WalkingHorse

Mark as read: Add to a list

Title	Upvotes	Author	Mark as read	Favorited	Rating	Add to a list
Patient-reported outcomes in CodeBreak 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation	1	WalkingHorse
Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer	1	WalkingHorse
BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer	1	WalkingHorse
Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer \| Cancer Epidemiology, Biomarkers & Prevention	1	WalkingHorse
Anaplastic Lymphoma Kinase-Tyrosine Kinase Inhibitor Treatment for Metastatic Non-small Cell Lung Cancer Throughout the Entire Gestation Period	1	WalkingHorse
Aspergillus fumigatus Is Dual-Tracer 18FDG/68Ga-FAPI PET/CT Capable of Distinguishing Fungal Infection and Unspecific Inflammation From Recurrent Lung Cancer?	1	WalkingHorse
FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A/STAT3 transcription mechanism \| Journal of Experimental & Clinical Cancer Research	1	WalkingHorse
A case of organizing pneumonia in rearranged during transfection fusion-positive lung adenocarcinoma treated with selpercatinib	1	WalkingHorse
Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth	1	WalkingHorse
Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer	1	WalkingHorse